Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Camp4 Therapeutics Corp roe for the quarter ending 2026-06-30 was 15475.32%, a change of 15604.82% year-over-year.
Camp4 Therapeutics Corp roe for the quarter ending 2026-03-31 was -279.27%, a change of -178.89% year-over-year.
Camp4 Therapeutics Corp roe for the quarter ending 2025-12-31 was -168.55%, a change of -86.53% year-over-year.
Camp4 Therapeutics Corp roe for the quarter ending 2025-09-30 was -91.02%, a 380.95% decline year-over-year.
Camp4 Therapeutics Corp roe for fiscal 2025 was -168.55%, a change of -86.53% from fiscal 2024.
Camp4 Therapeutics Corp roe for fiscal 2024 was -82.02%, a 305.89% decline from fiscal 2023.
Camp4 Therapeutics Corp roe for fiscal 2023 was 39.84%.